RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
RxSight (NASDAQ: RXST) will participate in the Stifel 2026 Virtual Ophthalmology Forum.
Rhea-AI Summary
RxSight (NASDAQ: RXST) will participate in the Stifel 2026 Virtual Ophthalmology Forum. Company management is scheduled for a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time.
A live and archived webcast will be accessible via RxSight’s investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – RXST
In the May 20 session, RXST gained 3.53%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Forum date
- May 26, 2026
- Stifel 2026 Virtual Ophthalmology Forum fireside chat
- Presentation time
- 10:00 a.m. Pacific Time
- Scheduled start of fireside chat
- Current price
- $6.00
- Price before Stifel forum news
- 52-week high
- $16.74
- Pre-news 52-week high reference
- 52-week low
- $5.30
- Pre-news 52-week low reference
- Price vs 52-week high
- -64.16%
- Distance from 52-week high before this news
- Volume today
- 735,652 shares
- Trading volume prior to publication
- 20-day avg volume
- 656,510 shares
- Average volume comparison baseline
Historical Context
-
Soft Q1 revenue, wider net loss, reiterated full‑year guidance.
-
Participation in Bank of America healthcare conference fireside chat.
-
Announcement of Q1 2026 results reporting date and call details.
-
Milestone of 300,000 Light Adjustable Lens implants and ASCRS presence.
-
Needham virtual healthcare conference fireside chat and webcast access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.